Antimicrobial susceptibility patterns of multidrug-resistant pseudomonas species against colistin and doripenem / Abeer Khaled Mokhtar Abuelazayem ; Supervised Mohamed Yousef Soliman , Lamiaa Abdelfattah Ahmed Madkour
Material type: TextLanguage: English Publication details: Cairo : Abeer Khaled Mokhtar Abuelazayem , 2016Description: 99 P. : facsimiles ; 25cmOther title:- اختبار حساسية السودوموناس متعددة المقاومة ضد الكوليستين و الدوريبينيم [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.19.M.Sc.2016.Ab.A (Browse shelf(Opens below)) | Not for loan | 01010110071248000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.19.M.Sc.2016.Ab.A (Browse shelf(Opens below)) | 71248.CD | Not for loan | 01020110071248000 |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Microbiology and Immunology
Multidrug resistant pseudomonas is one of the rapidly spreading bacteria causing infections with serious outcomes due to limited therapeutic options. Rapid spread of multidrug resistant bacteria (MDR) has become an emerging threat and a matter of concern worldwide. Our work aimed to screen for multi-drug resistance in 123 Pseudomonas isolates, and to detect the MDR Pseudomonas isolates up to the species level.Then, we evaluated the antimicrobial susceptibility patterns of MDR Pseudomonas to colistin and doripenem. The prevalence of MDR Pseudomonas in this study was 40.6%. Among different samples, 50% of MDR Pseudomonas isolates were retrieved from wound swabs, followed by 28% from sputum and 22% from urine. In this study, 98% of the included MDR Pseudomonas isolates were susceptible to colistin. As for doripenem, 58% of the isolates were sensitive, and 40% were resistant
Issued also as CD
There are no comments on this title.